Echocardıograpic Evalution of Hypertrophıc Cardıomyopathy in Cats Consıdered for Neutering
DOI:
https://doi.org/10.5281/zenodo.14561127Keywords:
Echocardiography, Cardiomyopathy, Hypertrophy, neutering, Left ventricular, CatAbstract
The aim of this study was to evaluate cardiac problems with echocardiography before ne-utering surgery in healthy cats.Sterilization is a surgical intervention to permanently stop the reproduction of animals. First, the body condition score of the cats coming to the clinic was evaluated, and it was deemed appropriate to perform echocardiography after taking blood and thorax radiography. In echocardiography studies, hypertrophic cardiomyopathy (HCM) was found to be a frequently reported heart disease in cats. Decisions were made to provide medi-cal treatment before sterilization. With measurements made using transthoracic echocardiog-raphy and 2D, M-mode and color Doppler imaging techniques, clear results were obtained about the thickness of the heart wall, the dimensions of the heart chambers and the pericar-dium. Statistically significant differences were revealed between left atrium and left ventricu-lar free wall thickness among cats (P < .001). Correct interpretation of the information obtai-ned from imaging methods and taking precautions are of great importance as they are life-saving for these patients. Developments in technology make significant contributions to the early detection of high-risk patients.
References
Austin BA, Popovic ZB, Kwon DH, et al. 2010. Aortic stiffness independently predicts exercise capacity in hypertrophic cardiomyopathy: a multimodality imaging study. He-art 2010;96(16):1303-10
BBC News. 2022. 4 Nisan Sokak Hayvanları Günü: Türkiye'de sokak hayvanları ne durumda ve neden tartışılıyor?
Bedard C, Lanevschi-Pietersma A, Dunn M, 2007. Evaluation of coagulation markers in the plasma of healthy cats and cats with asymptomatic hypertrophic cardiomyopathy. Vet Clin Pathol, 36, 167-172
Cremer PC, Geske JB, Owens A, et al. 2022. Myosin inhibition and left ventricular diastolic function in patients with obstructive hypertrophic cardiomyopathy referred for septal reduction therapy: insights from the VALOR-HCM Study. Circ Cardiovasc Ima-ging;15(12):e014986.
Desai MY, Owens A, Geske JB, et al.2023. Dose-blinded myosin inhibition in patients with obstructive hypertrophic cardiomyopathy referred for septal reduction therapy: outco-mes through 32 weeks. Circulation;147(11):850-863.
Dwyer L, 2015: Thromboembolic disease in dogs and cats. Veterinary Nursing Journal, 30, 118.
Dybro AM, Rasmussen TB, Nielsen RR, et al. 2022. Effects of metoprolol on exercise hemodynamics in patients with obstructive hypertrophic cardiomyopathy.J Am Coll Cardiol.;79(16):
Heitner SB, Jacoby D, Lester SJ, et al.2019. Mavacamten treatment for obstructive hypertrop-hic cardiomyopathy: a clinical trial. Ann Intern Med;170(11):741-748.
Hogan DF, 2017. Feline Cardiogenic Arterial Thromboembolism. Vet Clin Small Anim, 47, 1065- 1082.
Kang ME, Min SH, Kim SG, Lee CM, Park HM, 2015. Characteristic Clinical Features and Survival in Cats with Symptomatic Hypertrophic Cardiomyopathy. J Biomed Res, 16, 152-158.
Maron BJ.2002. Hypertrophic cardiomyopathy: A systematic review. JAMA ;287(10):1308-20
Maron BJ, Desai MY, Nishimura RA, et al.2022. Management of hypertrophic cardiomyo-pathy: JACC state-of-the-art review.J Am Coll Cardiol;79(4):390-414
Mun JB, Oh AR, Park HS, et al.2013. The Unusual Suspect: Anemia-induced Systolic Anterior Motion of the Mitral Valve and Intraventricular Dynamic Obstruction in a Hyperdynamic Heart as Unexpected Causes of Exertional Dyspnea after Cardiac Sur-gery. Korean J Thorac Cardiovasc Surg;46(6):457-60.
Nagueh SF, Lakkis NM, Middleton KJ, et al. 1999. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation;99(2):254-61.
Nagueh SF, Bierig SM, Budoff MJ, et al.2011 American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypert-rophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Com-puted Tomography. J Am Soc Echocardiogr ;24(5):473-98.
Nguyen A, Schaff HV, Ommen SR, et al. 2021.Late health status of patients undergoing myectomy for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg.;111(6):1867-1875.
Payne JR, Borgeat K, Connolly DJ, Boswood A, Dennis S, Wagner T, Menaut P, Maerz I, Evans D, Simons VE, Brodbelt DC, Luis Fuentes V, 2013. Prognostic indicators in cats with hypertrophic cardiomyopathy. J Vet Intern Med, 27, 1427-1436.
Rassiah P., Su, F.-C.F., Huang, Y.J., Spitznagel, D., Sarkar, V., Szegedi, M.W., Zhao, H., Paxton, A.B., Nelson, G. & Salter, B.J. 2020. Using failure mode and effects analysis (FMEA) to generate an initial plan check checklist for improved safety in radiation tre-atment. Journal of Applied Clinical Medical Physics, 21(8), 83-91.
Rush JE., Freeman LM., Fenollosa NK., Brown DJ., 2002. Population and survival characte-ristics of cats with hypertrophic cardiomyopathy: 260 cases (1990– 1999). J Am Vet Med Assoc, 220, 202–207.
Stokol T, Brooks M, Rush JE, Rishniw M, Erb H, Rozanski E, Kraus MS, Gelzer AR, 2008. Hypercoagulability in cats with cardiomyopathy. J Vet Intern Med, 22, 546-552.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 EJONS INTERNATIONAL JOURNAL
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
